Early IL-4 production does not predict susceptibility to Leishmania major

Experimental Parasitology

Volumn 84, Issue 2, 1996, Pages 178-187

  Scott, Phillip ^a,b   Eaton, Ashlyn ^b   Gause, William C ^a   Zhou, Xia D I ^a   Hondowicz, Brian ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 4;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HOST SUSCEPTIBILITY; IMMUNE RESPONSE; LEISHMANIA MAJOR; LEISHMANIASIS; MOUSE; NONHUMAN; PREDICTION; PRIORITY JOURNAL;

ANIMALIA; LEISHMANIA MAJOR;

EID: 0030298147     PISSN: 00144894     EISSN: None     Source Type: Journal    
DOI: 10.1006/expr.1996.0103     Document Type: Article

References (30)

1. BECKMAN, M. P., SCHOOLEY, K. A. GALLIS, B., VANDEN BOS, T., FRIEND, D., ALPERT, A. R., RAUNIO, R., PRICKETT, K. S., BAKER, P. E., AND PARK, L. S. 1990. Monoclonal antibodies block murine IL-4 receptor function. Journal of Immunology 144, 4212-A217.
2. BEHIN, R., MAUEL, J., AND SORDAT, B. 1979. Leishmania tropica: Pathogenicity and in vitro macrophage function in strains of inbred mice. Experimental Parasitology 48, 81-91.
3. CAMPBELL, K. A., OVENDALE, P. J., KENNEDY, M. K., FANSLOW, W. C., REED, S. G., AND MALISZEWSKI, C. R. 1996. CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity 4, 283-290.
4. CHATELAIN, R., VARKILA, K., AND COFFMAN, R. L. 1992. IL-4 induces a Th2 response in Leishmania major-infected mice. Journal of Immunology 148, 1182-1187.
5. GAUSE, W. C., AND ADAMOVICZ, J. 1994. The use of PCR to quantitate gene expression. PCR Methods and Applications 3, S123-S135.
6. GULER, M. L., GORHAM, J. D., HSIEH, C.-S., MACKEY, A. J., STEEN, R. G., DIETRICH, W. F., AND MURPHY, K. M. 1996. Genetic susceptibility to Leishmania: IL-12 responsiveness in Th1 cell development. Science 271, 984-986.
7. HEINZEL, F. P., SADICK, M. D., HOLADAY, B. J., COFFMAN, R. L., AND LOCKSLEY, R. M. 1989. Reciprocal expression of Interferon gamma or IL4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. Journal of Experimental Medicine 169, 59-72.
8. HEINZEL, F. P., SCHOENHAUT, D. S., RERKO, R. M., ROSSER, L. E., AND GATELY, M. K. 1993. Recombinant Interleukin 12 cures mice infected with Leishmania major. Journal of Experimental Medicine 177, 1505-1509.
9. HSIEH, C.-S., HEIMBERGER, A. B., GOLD, J. S., O'GARRA, A., AND MURPHY, K. M. 1992. Differential regulation of T helper phenotype development by interleukins 4 and 10 in an a,b T-cell-receptor transgenic system. Proceedings of the National Academy of Sciences, U.S.A. 89, 6065-6069.
10. HSIEH, C.-S., MACATONIA, S. E., TRIPP, C. S., WOLF, S. F., O'GARRA, A., AND MURPHY, K. M. 1993. Development of Th1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 260, 547-549.
11. KAMANAKA, M., YU, P., YASUI, T., YOSHIDA, K., KAWABE, T., HORII, T., KISHTMOTO, T., AND KIKUTANI, H. 1996. Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity. Immunity 4, 275-282.
12. LAUNOIS, P., OHTEKI, T., SWIHART, K., MACDONALD, H. R., AND LOUIS, J. A. 1996. In susceptible mice, Leishmania major induce very rapid interleukin-4 production by CD4+ T cells which are NK1.1-. European Journal of Immunology 25, 3298-3307.
13. MORRIS, L., TROUTT, A. B., HANDMAN, E., AND KELSO, A. 1992. Changes in the precursor frequencies of IL-4 and IFN-g secreting CD4+ cells correlate with resolution of lesions in murine cutaneous leishmaniasis. Journal of Immunology 149, 2715-2721.
14. MORRIS, S. C., MADDEN, K. B., ADAMOVICZ, J. J., CAUSE, W. C., HUBBARD, B. R., GATELY, M. K., AND FINKELMAN, F. D. 1994. Effects of IL-12 on in vivo cytokine gene expression and Ig isotype selection. Journal of Immunology 152, 1047-1056.
15. NOBEN-TRAUTH, N., KROPF, P., AND MULLER, I. 1996. Susceptibility to Leishmania major infection in interleukin-4-deficient mice. Science 271, 987-990.
16. REINER, S. L., ZHENG, S., WANG, Z.-E., STOWRING, L., AND LOCKSLEY, R. M. 1994. Leishmania promastigotes evade interleukin 12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells during initiation of infection. Journal of Experimental Medicine 179, 447-456.
17. SACKS, D. H., AND PERKINS, P. V. 1984. Identification of an infective stage of Leishmania promastigotes. Science 223, 1417-1410.
18. SADICK, M. D., HEINZEL, F. P., HOLADAY, B. J., PU, R. T., DAWKINS, R. S., AND LOCKSLEY, R. M. 1990. Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, Interferon gamma-independent mechanism. Journal of Experimental Medicine 171, 115-127.
19. SCHARTON, T. M., AND SCOTT, P. 1993. Natural killer cells are a source of IFN-g that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice. Journal of Experimental Medicine 178, 567-577.
20. SCHARTON-KERSTEN, T., AFONSO, L. C. C., WYSOCKA, M., TRINCHIERI, G., AND SCOTT, P. 1995. IL-12 is required for Natural Killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. Journal of Immunology 154, 5320-5330.
21. SCOTT, P. 1991. IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis. Journal of Immunology 147, 3149-3155.
22. SCOTT, P. 1995. T helper cell development and regulation in experimental cutaneous leishmaniasis. Chemical Immunology 63, 00-00.
23. SCOTT, P., HONDOWICZ, B., EATON, A., AND SCHARTON-KERSTEN, T. 1996. The role of IL-12 in regulation of T helper cell subsets in vivo: Lessons from experimental cutaneous leishmaniasis. Annals of the New York Academy of Sciences, in press
24. SCOTT, P., AND SCHARTON, T. M. 1994. Interactions between the innate and the acquired immune system following infection of different mouse strains with Leishmania major. Annals of the New York Academy of Sciences 730, 84-92.
25. SEDER, R. A., PAUL, W. E., DAVIS, M. M., AND FAZEKAS, DE ST.GROTH, B. 1992. The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice. Journal of Experimental Medicine 176, 1091-1098.
26. SEDER, R. A., GAZZMELLI, R., SHER, A., AND PAUL, W. E. 1993. Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming. Proceedings of the National Academy of Sciences, USA 90, 10188-10192.
27. SOONG, L., SU, J.-C., GREWAL, I. S., KIMA, P., SUN, J., LONGLEY, B. J., RUDDLE, N. H., MCMAHON-PRATT, D., AND FLAVELL, R. A. 1996. Disruption of CD40-CD40 ligand interactions results in enhanced susceptibility to Leishmania amazonensis infection. Immunity 4, 263-274.
28. STENGER, R., DONHAUSER, N., THURING, H., ROLLINGHOFF, M., AND BOGDAN, C. 1996. Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase. Journal of Experimental Medicine 183, 1501-1514.
29. SYPEK, J. P, CHUNG, C. L., MAYOR, S. E. H., SUBRAMANYAM, J. M., GOLDMAN, S. J., SIEBURTH, D. S., WOLF, S. F., AND SCHAUB, R. G. 1993. Resolution of cutaneous leishmaniasis: Interleukin 12 initiates a protective Th1 immune response. Journal of Experimental Medicine 177, 1797-1802.
30. WANG, Z. E., ZHENG, S., CORRY, D. B., DALTON, D. K., SEDER, R. A., REINER, S. L., AND LOCKSLEY, R. M. 1994. Interferon gamma-independent effects of interleukin 12 administered during acute or established infection due to Leishmania major. Proceedings of the National Academy of Sciences, U.S.A. 91, 12932-12936.